| mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
| mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.02 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
| mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
| mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |